NYSE · Drug Manufacturers - General
AbbVie Inc (ABBV)
$294.89
+1.41%
73
Overbought
Moving averages
SMA 200$232.91+26.61%
Company profile
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$496.77B
P/E ratio79.41
EPS$3.54
Beta0.228
Dividend yield2.47%
52-week high$283.31
52-week low$189.40
ETFs holding ABBV
Similar stocks in Drug Manufacturers - General
RSI alerts for ABBV
An email when ABBV closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 8:43 PM EDT